RxDoctor Payments Data

Susanne Lane Sandt

Family · Allentown, PANPI 1891963427

Payments from drug & device makers

$811in general payments, 2019–2025

Across 44 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$297
  • Scilex Pharmaceuticals Inc.$117
  • AbbVie$98
  • Regeneron Healthcare Solutions, Inc.$55
  • Collegium Pharmaceutical, Inc.$48
  • Lilly USA, LLC$43
  • plus $153 from 6 others

What the payments were for

  • Food & beverage$811100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$811 in reported general payments places this provider in the 65th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$49,895
Medicare patients
480
Services billed
626

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide56$57,545
EliquisApixaban21$9,182
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates104$6,721
Lubiprostone19$4,676
Pantoprazole Sodium254$4,123
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog32$3,833
Omeprazole272$3,602
Rabeprazole Sodium19$2,549
Colestipol Hcl26$2,470
Rivastigmine11$2,049
Amlodipine Besylate80$1,858
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine47$1,829
Famotidine133$1,698
Metformin Hcl66$1,610
Gabapentin65$1,600

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$98$57,54556 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,717 family providers in Pennsylvania.

Other family in Allentown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →